The prognosis for testicular cancer is excellent, with a 5-year survival rate greater than 95%. Patients affected can therefore expect to be cured after treatment. Successful treatment requires assessment of the condition at the various stages of its management. Imaging plays a major role in initial analysis of the lymphatic extension and in looking for metastases. It is essential for evaluating the response to treatment and during follow-up after treatment. CT is the most commonly used imaging method in this context, but the role of PET is currently developing. The purpose of this paper is to review the role of the imaging methods commonly used in the management of testicular cancer. © 2012 Published by Elsevier Masson SAS on behalf of the Éditions françaises de radiologie.
Brunereau, L., Bruyère, F., Linassier, C., & Baulieu, J. L. (2012). The role of imaging in staging and monitoring testicular cancer. Diagnostic and Interventional Imaging, 93(4), 310–318. https://doi.org/10.1016/j.diii.2012.01.014